Noopept protects ciliates Paramecium сaudatum cells from the toxic effects of heavy metal compounds [PDF]
Background. The dipeptide drug Noopept, created at the Zakusov Institute of Pharmacology, has a wide range of pharmacological actions, including cytoprotective one.
O. V. Karpukhina +2 more
doaj +5 more sources
Comparative study of pharmacokinetics and enzymatic resistance of the neuroprotective mean GZK-111 and noopept in rats [PDF]
The article presents the results of studying the pharmacokinetics and enzymatic stability of a new pharmacologically active compound GZK-111– N-phenylacetyl-glycyl-L-proline ethyl ether in comparison with noopept – N-phenylacetyl-L-prolyl-glycine ethyl ...
S. S. Boyko +2 more
doaj +5 more sources
Morpho-functional parameters of neurons in the sensorimotor cortex and neuroapoptosis under conditions of an induced experimental allergic encephalomyelitis in rats and a course of intranasal gel administration containing n-phenylacetyl-l-prolylglycine (N [PDF]
Purpose. The aim of the research is to evaluate a neuroprotective effect of the nasal dosage form containing Noopept (n-phenylacetyl-l-prolylglycine ethyl ester) by the degree of influence on morphofunctional parameters of neurons in the sensorimotor ...
B. S. Burlaka +3 more
doaj +3 more sources
There are largely unknown associations between changes in pain behavior responses during persistent peripheral inflammation and spinal cell alteration such as apoptosis.
Mona Taghizadeh +8 more
doaj +2 more sources
Pharmacokinetics and neurotropic effects of cyclo-L-prolylglycine and its modified analogues [PDF]
The review presents the results of studies on the pharmacokinetics, metabolism, and bioavailability of new neurotropic dipeptide cyclo-Lprolilglycine (CPG) and their pharmacological activity.
S. S. Boyko +2 more
doaj +5 more sources
A study on toxicity, local irritative effect of and allergic response to a novel intranasal medication containing N-phenylacetyl-L-prolylglycine ethyl ester [PDF]
Development of novel medications for delivery of active ingredients with systemic absorption and high bioavailability is an actual challenge for modern pharmaceutical and medical science.
B. S. Burlaka, I. F. Bielenichev
doaj +3 more sources
Neuroprotective properties of n-phenylacetyl-l-prolylglycine ethyl ester nasal gel in an experimental model of multiple sclerosis equivalent [PDF]
The purpose of this research is to study the specific activity of our developed nasal dosage form with n-phenylacetyl-l-prolylglycine ethyl ester. The experiments were performed on 260 white outbred rats weighing 190-220 g.
B.S. Burlaka +4 more
doaj +4 more sources
Comparative pharmacokinetics and pharmacodinamics of noopept, its activity metabolite cycloprolylglycine and piracetam [PDF]
While studing of experimental pharmacokinetics of the peptide analogues piracetam noopept - N-phenylacetyl-L-prolyl-glycine ethyl ester, was found the active metabolite that identificated as cyclo-L-prolylglycine (CPG).
Svetlana Boyko +2 more
doaj +3 more sources
The study of the permeability of the blood-brain barrier for new neurotropic peptide drugs [PDF]
The paper presents the results of studies of penetration through the hemato-encephalic barrier (BBB) of rats of three new peptide drugs -modified analogues of endogenous neuropeptides and their active metabolites created in the research Zakusov institute
V. P. Zherdev +2 more
doaj +5 more sources
The Occurrence of Illicit Smart Drugs or Nootropics in Europe and Australia and Their Associated Dangers: Results from a Market Surveillance Study by 12 Official Medicines Control Laboratories [PDF]
In recent years, an increasing number of case reports have mentioned the presence of illicit nootropics, smart drugs or mind doping products on the market.
Celine Vanhee +18 more
doaj +2 more sources

